This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Plo, I. Articles by Lopez, B. S. Search for Related Content PubMed PubMed Citation Articles by Plo, I. Articles by Lopez, B. S.

AKT1 Inhibits Homologous Recombination by Inducing Cytoplasmic Retention of BRCA1 and RAD51

¹ Unité Mixte de Recherche Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique (CNRS) 217; ² Institut de Radiobiologie Cellulaire et Moléculaire, CEA, Fontenay-aux-Roses, France and ³ Institut National de la Sante et de la Recherche Medicale; ⁴ University of Paris 7; and ⁵ AP-HP, Hôpital Saint Louis, Clinical Investigation Center, Paris, France

Requests for reprints: Bernard S. Lopez, Unité Mixte de Recherche Centre National de la Recherche Scientifique (CNRS)/Commissariat à l'Energie Atomique (CEA) 217, CEA, Fontenay aux Roses, 92265, France. Phone: 33-01-46-54-88-35; Fax: 33-01-46-54-89-55; E-mail: bernard.lopez{at}cea.fr.

Key Words: AKT • Breast cancer • Homologous Recombination

AKT1 is frequently up-regulated in sporadic breast cancer, whereas BRCA1 is frequently mutated in familial breast cancer. Because BRCA1 is involved in homologous recombination (HR), we addressed whether AKT1 also has an effect on this process. We showed that AKT1 repressed HR through cytoplasmic retention of BRCA1 and RAD51 proteins, resulting in a BRCA1-deficient–like phenotype. This process does not require direct BRCA1 phosphorylation by AKT1. The cytoplasmic retention of BRCA1 and RAD51 correlated with activated AKT1 in tumor cell lines and in biopsies from sporadic breast cancers. Under nonpathologic conditions, fibroblast growth factor, which activates AKT1 and stimulates proliferation in fibroblasts, impaired excessive HR without fully inhibiting it, promoting genome stability. Our study reveals that the regulation of BRCA1 and RAD51 is altered in a high frequency of sporadic breast cancers and highlights the role of extracellular AKT signaling-dependent regulation of HR and genome stability. [Cancer Res 2008;68(22):9404–12]

This article has been cited by other articles:

				X. Wu, G. Mondal, X. Wang, J. Wu, L. Yang, V. S. Pankratz, M. Rowley, and F. J. Couch Microcephalin Regulates BRCA2 and Rad51-Associated DNA Double-Strand Break Repair Cancer Res., July 1, 2009; 69(13): 5531 - 5536. [Abstract] [Full Text] [PDF]